FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-116087.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-116087v1
23/6/1672    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ingram, R. J.
Right arrow Articles by Altmann, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ingram, R. J.
Right arrow Articles by Altmann, D. M.
(The FASEB Journal. 2009;23:1672-1684.)
© 2009 FASEB

A role of cellular prion protein in programming T-cell cytokine responses in disease

Rebecca J. Ingram*,1, Jeremy D. Isaacs*,{dagger},1, Gurman Kaur*,2, Daniel E. Lowther*, Catherine J. Reynolds{ddagger}, Rosemary J. Boyton{ddagger}, John Collinge{dagger}, Graham S. Jackson{dagger} and Daniel M. Altmann*,3

* Human Disease Immunogenetics Group, Department of Infectious Diseases and Immunity, Hammersmith Hospital, Imperial College London, London, UK;

{dagger} MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, UK; and

{ddagger} Lung Immunology Group, Immunology and Infection/NHLI, Sir Alexander Fleming Building, South Kensington Campus, Imperial College London, London, UK

3Correspondence: Dept. of Infectious Diseases and Immunity, Imperial College London, Hammersmith Hospital, Du Cane Rd., London W12 0NN, UK. E-mail: d.altmann{at}imperial.ac.uk

The cellular prion protein (PrPC) is widely expressed in neural and non-neural tissues, but its function is unknown. Elucidation of the part played by PrPC in adaptive immunity has been a particular conundrum: increased expression of cell surface PrPC has been documented during T-cell activation, yet the functional significance of this activation remains unclear, with conflicting data on the effects of Prnp gene knockout on various parameters of T-cell immunity. We show here that Prnp mRNA is highly inducible within 8–24 h of T-cell activation, with surface protein levels rising from 24 h. When measured in parallel with CD69 and CD25, PrPC is a late activation antigen. Consistent with its up-regulation being a late activation event, PrP deletion did not alter T-cell-antigen presenting cell conjugate formation. Most important, activated PrP0/0 T cells demonstrated much reduced induction of several T helper (Th) 1, Th2, and Th17 cytokines, whereas others, such as TNF-{alpha} and IL-9, were unaffected. These changes were investigated in the context of an autoimmune model and a bacterial challenge model. In experimental autoimmune encephalomyelitis, PrP-knockout mice showed enhanced disease in the face of reduced IL-17 responses. In a streptococcal sepsis model, this constrained cytokine program was associated with poorer local control of infection, although with reduced bacteremia. The findings indicate that PrPC is a potentially important molecule influencing T-cell activation and effector function—Ingram, R. J., Isaacs, J. D., Kaur, G., Lowther, D. E., Reynolds, C. J., Boyton, R. J., Collinge, J., Jackson, G. S., Altmann, D. M. A role of cellular prion protein in programming T-cell cytokine responses in disease.


Key Words: T lymphocyte • knockout mouse • Th17




This article has been cited by other articles:


Home page
BrainHome page
W. Hu, S. Nessler, B. Hemmer, T. N. Eagar, L. P. Kane, S. R. Leliveld, A. Muller-Schiffmann, A. R. Gocke, A. Lovett-Racke, L.-H. Ben, et al.
Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling
Brain, February 9, 2010; (2010) awp298v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.